The Latest: Pfizer: US regulators OK 'priority review'
NEW YORK - Pfizer announced U.S. regulators have agreed to a "priority review" of whether its COVID-19 vaccine should be fully approved, with a decision set for no later than Janua…
NEW YORK - Pfizer announced U.S. regulators have agreed to a "priority review" of whether its COVID-19 vaccine should be fully approved, with a decision set for no later than Janua…